Aqueous suspension composition containing sirolimus or salt thereof
AssigneeSanten Pharmaceutical Co., Ltd.
InventorsToyomi FUJISAWA, Ayaka AKUTAGAWA
Life of this patent
Estimating the term…
Abstract
The purpose of the present invention is to provide an aqueous suspension composition comprising poorly water-soluble sirolimus or a salt thereof for ophthalmology, in particular, used for topical administration, such as a less invasive eye drop. The present invention is an ophthalmic aqueous suspension composition comprising sirolimus or a salt thereof and a surfactant, wherein the aqueous suspension composition has a pH of 4 to 6.
Claims17
An ophthalmic aqueous suspension composition comprising sirolimus or a salt thereof and a surfactant, wherein
- the aqueous suspension composition has a pH of 4 to 6.
An ophthalmic aqueous suspension composition comprising sirolimus or a salt thereof and polysorbate 80, wherein
- a content of sirolimus or a salt thereof is from 0.01 to 1% (w/v),
- a content ratio of the polysorbate 80 to sirolimus or a salt thereof is from 0.1 to 10 parts by weight based on 1 part by weight of a content of sirolimus or a salt thereof,
- sirolimus or a salt thereof in the aqueous suspension composition has an average particle size of 2.5 μm or less, and
- the aqueous suspension composition has a pH of 4 to 6.
-20. (canceled)
Dependencies are inferred from the claim text.